title: Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.
authors.forename: T
authors.initials: T
authors.lastname: Bains
authors.forename: M C
authors.initials: MC
authors.lastname: Heinrich
authors.forename: M M
authors.initials: MM
authors.lastname: Loriaux
authors.forename: C
authors.initials: C
authors.lastname: Beadling
authors.forename: D
authors.initials: D
authors.lastname: Nelson
authors.forename: A
authors.initials: A
authors.lastname: Warrick
authors.forename: T L
authors.initials: TL
authors.lastname: Neff
authors.forename: J W
authors.initials: JW
authors.lastname: Tyner
authors.forename: J
authors.initials: J
authors.lastname: Dunlap
authors.forename: C L
authors.initials: CL
authors.lastname: Corless
authors.forename: G
authors.initials: G
authors.lastname: Fan
mesh_terms: D000328:Adult; D002648:Child; D006801:Humans; D053616:Janus Kinase 3 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate
chemical_list: C507933:JAK3 protein, human; D053616:Janus Kinase 3